Lotus Eye Hospital and Institute Ltd
NSE:LOTUSEYE
Lotus Eye Hospital and Institute Ltd
NSE:LOTUSEYE
Price:
106
INR
-1.83%
Market Closed
Market Cap:
₹2.2B
Relative Value
The Relative Value of one
LOTUSEYE
stock under the Base Case scenario is
75.88
INR.
Compared to the current market price of 106 INR,
Lotus Eye Hospital and Institute Ltd
is
Overvalued by 28%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LOTUSEYE
Relative Value
Base Case
75.88
INR
Overvaluation 28%
Multiples Across Competitors
LOTUSEYE Competitors Multiples
Lotus Eye Hospital and Institute Ltd Competitors
Lotus Eye Hospital and Institute Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Lotus Eye Hospital and Institute Ltd
NSE:LOTUSEYE
|
2.2B INR | 4.3 | 337.9 | 72 | 327.2 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
114.6B USD | 1.5 | 16.9 | 9.9 | 12.8 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 7.1 | 40.8 | 31.9 | 40 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
22.1B ZAR | 0.8 | 13.1 | 8.9 | 8.9 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
78.9B MYR | 3.2 | 39.5 | 16.1 | 24.1 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
17.7B USD | 0.8 | 12.6 | 6 | 7.3 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
16B ZAR | 0.6 | 4.1 | 16.4 | -47.5 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
82.5B BRL | 1.5 | 17.5 | 7.5 | 8.9 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
94.9B CNY | 4.3 | 29.6 | 21.2 | 21.2 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
11.9B USD | 2.3 | 34.2 | 21.4 | 26.7 | |
| US |
|
Universal Health Services Inc
NYSE:UHS
|
11.6B USD | 0.7 | 7.8 | 5.8 | 7.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
